Categories AlphaGraphs, Earnings, Health Care
MEDS Earnings: A snapshot of Trxade Health’s Q3 2023 financial results
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the third quarter of 2023. There was a double-digit increase in service revenues.
Total revenues remained broadly unchanged at $2.06 million in the September quarter. An increase in service revenues was offset by a decline in product revenues.
Net loss attributable to Trxade Health was $3.53 million or $0.07 per share in the third quarter, compared to a loss of $0.53 million or $0.57 per share in the same period of last year.
Total registered users on the TRxADE platform increased by 870 or 6.17% compared to September 2022. For the nine months ended September 2023, new registrations were 196, compared to 296 for the same period in 2022. The company had a total of around 14,900+ registered members at the end of the quarter.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on